Jacob Couturier1, Dorothy E Lewis2. 1. Division of Infectious Diseases, Department of Internal Medicine, The University of Texas Health Science Center at Houston, 6431 Fannin St., MSB 2.112, Houston, TX, 77030, USA. 2. Division of Infectious Diseases, Department of Internal Medicine, The University of Texas Health Science Center at Houston, 6431 Fannin St., MSB 2.112, Houston, TX, 77030, USA. dorothy.e.lewis@uth.tmc.edu.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to examine the evidence describing adipose tissue as a reservoir for HIV-1 and how this often expansive anatomic compartment contributes to HIV persistence. RECENT FINDINGS: Memory CD4 T cells and macrophages, the major host cells for HIV, accumulate in adipose tissue during HIV/SIV infection of humans and rhesus macaques. Whereas HIV and SIV proviral DNA is detectable in CD4 T cells of multiple fat depots in virtually all infected humans and monkeys examined, viral RNA is less frequently detected, and infected macrophages may be less prevalent in adipose tissue. However, based on viral outgrowth assays, adipose-resident CD4 T cells are latently infected with virus that is replication-competent and infectious. Additionally, adipocytes interact with CD4 T cells and macrophages to promote immune cell activation and inflammation which may be supportive for HIV persistence. Antiviral effector cells, such as CD8 T cells and NK/NKT cells, are abundant in adipose tissue during HIV/SIV infection and typically exceed CD4 T cells, whereas B cells are largely absent from adipose tissue of humans and monkeys. Additionally, CD8 T cells in adipose tissue of HIV patients are activated and have a late differentiated phenotype, with unique TCR clonotypes of less diversity relative to blood CD8 T cells. With respect to the distribution of antiretroviral drugs in adipose tissue, data is limited, but there may be class-specific penetration of fat depots. The trafficking of infected immune cells within adipose tissues is a common event during HIV/SIV infection of humans and monkeys, but the virus may be mostly transcriptionally dormant. Viral replication may occur less in adipose tissue compared to other major reservoirs, such as lymphoid tissue, but replication competence and infectiousness of adipose latent virus are comparable to other tissues. Due to the ubiquitous nature of adipose tissue, inflammatory interactions among adipocytes and CD4 T cells and macrophages, and selective distribution of antiretroviral drugs, the sequestration of infected immune cells within fat depots likely represents a major challenge for cure efforts.
PURPOSE OF REVIEW: The purpose of this review is to examine the evidence describing adipose tissue as a reservoir for HIV-1 and how this often expansive anatomic compartment contributes to HIV persistence. RECENT FINDINGS: Memory CD4 T cells and macrophages, the major host cells for HIV, accumulate in adipose tissue during HIV/SIV infection of humans and rhesus macaques. Whereas HIV and SIV proviral DNA is detectable in CD4 T cells of multiple fat depots in virtually all infected humans and monkeys examined, viral RNA is less frequently detected, and infected macrophages may be less prevalent in adipose tissue. However, based on viral outgrowth assays, adipose-resident CD4 T cells are latently infected with virus that is replication-competent and infectious. Additionally, adipocytes interact with CD4 T cells and macrophages to promote immune cell activation and inflammation which may be supportive for HIV persistence. Antiviral effector cells, such as CD8 T cells and NK/NKT cells, are abundant in adipose tissue during HIV/SIV infection and typically exceed CD4 T cells, whereas B cells are largely absent from adipose tissue of humans and monkeys. Additionally, CD8 T cells in adipose tissue of HIVpatients are activated and have a late differentiated phenotype, with unique TCR clonotypes of less diversity relative to blood CD8 T cells. With respect to the distribution of antiretroviral drugs in adipose tissue, data is limited, but there may be class-specific penetration of fat depots. The trafficking of infected immune cells within adipose tissues is a common event during HIV/SIV infection of humans and monkeys, but the virus may be mostly transcriptionally dormant. Viral replication may occur less in adipose tissue compared to other major reservoirs, such as lymphoid tissue, but replication competence and infectiousness of adipose latent virus are comparable to other tissues. Due to the ubiquitous nature of adipose tissue, inflammatory interactions among adipocytes and CD4 T cells and macrophages, and selective distribution of antiretroviral drugs, the sequestration of infected immune cells within fat depots likely represents a major challenge for cure efforts.
Entities:
Keywords:
Adipose tissue; Antiretroviral therapy; CD4 T cells; HIV reservoir; Immunometabolism; Obesity
Authors: Tuo Deng; Christopher J Lyon; Stephen Bergin; Michael A Caligiuri; Willa A Hsueh Journal: Annu Rev Pathol Date: 2016-05-23 Impact factor: 23.472
Authors: M Sievers; U A Walker; K Sevastianova; B Setzer; D Wågsäter; P Eriksson; H Yki-Järvinen; J Sutinen Journal: J Infect Dis Date: 2009-07-15 Impact factor: 5.226
Authors: Nikhil V Dhurandhar; Leah D Whigham; David H Abbott; Nancy J Schultz-Darken; Barbara A Israel; Steven M Bradley; Joseph W Kemnitz; David B Allison; Richard L Atkinson Journal: J Nutr Date: 2002-10 Impact factor: 4.798
Authors: Shashi Shrivastav; Tomoshige Kino; Tshaka Cunningham; Takamasa Ichijo; Ulrich Schubert; Peter Heinklein; George P Chrousos; Jeffrey B Kopp Journal: Mol Endocrinol Date: 2007-10-11
Authors: Anita C A Dankers; Fred C G J Sweep; Jeanne C L M Pertijs; Vivienne Verweij; Jeroen J M W van den Heuvel; Jan B Koenderink; Frans G M Russel; Rosalinde Masereeuw Journal: Cell Tissue Res Date: 2012-05-13 Impact factor: 5.249
Authors: Serena Spudich; Kevin R Robertson; Ronald J Bosch; Rajesh T Gandhi; Joshua C Cyktor; Hanna Mar; Bernard J Macatangay; Christina M Lalama; Charles Rinaldo; Ann C Collier; Catherine Godfrey; Joseph J Eron; Deborah McMahon; Jana L Jacobs; Dianna Koontz; Evelyn Hogg; Alyssa Vecchio; John W Mellors Journal: J Clin Invest Date: 2019-07-15 Impact factor: 14.808
Authors: Greg S Gojanovich; Cecilia M Shikuma; Cris Milne; Daniel E Libutti; Dominic C Chow; Mariana Gerschenson Journal: AIDS Res Hum Retroviruses Date: 2019-09-17 Impact factor: 2.205
Authors: Francoise A Gourronc; Michael R Rebagliati; Breanna Kramer-Riesberg; Anthony M Fleck; J J Patten; Kathleen Geohegan-Barek; Kelly N Messingham; Robert A Davey; Wendy Maury; Aloysius J Klingelhutz Journal: Virology Date: 2022-05-27 Impact factor: 3.513
Authors: Antoine Chaillon; Sara Gianella; Simon Dellicour; Stephen A Rawlings; Timothy E Schlub; Michelli Faria De Oliveira; Caroline Ignacio; Magali Porrachia; Bram Vrancken; Davey M Smith Journal: J Clin Invest Date: 2020-04-01 Impact factor: 14.808
Authors: Joshua C Cyktor; Ronald J Bosch; Hanna Mar; Bernard J Macatangay; Ann C Collier; Evelyn Hogg; Catherine Godfrey; Joseph J Eron; Deborah K McMahon; John W Mellors; Rajesh T Gandhi Journal: J Infect Dis Date: 2021-02-13 Impact factor: 7.759
Authors: W M Han; A Jiamsakul; J Jantarapakde; E Yunihastuti; J Y Choi; R Ditangco; R Chaiwarith; L P Sun; S Khusuwan; T P Merati; C D Do; I Azwa; M-P Lee; K Van Nguyen; Y-J Chan; S Kiertiburanakul; O T Ng; J Tanuma; S Pujari; F Zhang; Y M Gani; S Sangle; J Ross; N Kumarasamy Journal: HIV Med Date: 2020-11-17 Impact factor: 3.180
Authors: Neeti Agarwal; Dinakar Iyer; Pradip Saha; Aaron R Cox; Yan Xia; Netanya S Utay; Anoma Somasundaram; Ulrich Schubert; Jordan E Lake; Sean M Hartig; Ashok Balasubramanyam Journal: Diabetes Date: 2021-07-07 Impact factor: 9.337
Authors: Arianna Kousari; Carlee Moser; Maxine Olefsky; Todd T Brown; Judith S Currier; Grace A McComsey; Ann Scherzinger; James H Stein; Jordan E Lake; Kristine M Erlandson Journal: J Acquir Immune Defic Syndr Date: 2021-12-01 Impact factor: 3.771